Brimonidine (UK 14304) is a full α2-adrenergic receptor (α2-AR) agonist.
性状
Solid
IC50 & Target[1][2]
α2-adrenergic Receptor.
体外研究(In Vitro)
[3H]Brimonidine (UK 14304) is a full agonist at alpha 2-adrenergic receptors. [3H]Brimonidine (UK 14304) labels at least 2 specific binding sites in human brain that both have the characteristics of an alpha 2-adrenergic binding site. GTP decreases agonist binding at both of these sites, but with different potencies at each site [1-3].
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.